Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.
Identifieur interne : 000161 ( PubMed/Curation ); précédent : 000160; suivant : 000162Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.
Auteurs : Kristian M. Hargadon [États-Unis] ; Haixia Zhou ; Randy A. Albrecht ; Haley A. Dodd ; Adolfo García-Sastre ; Thomas J. BracialeSource :
- Journal of virology [ 1098-5514 ] ; 2011.
Descripteurs français
- KwdFr :
- Animaux, Antigènes d'histocompatibilité de classe II (biosynthèse), Antigènes d'histocompatibilité de classe II (immunologie), Cellules dendritiques (immunologie), Cellules dendritiques (virologie), Expression des gènes, Femelle, Glycoprotéine hémagglutinine du virus influenza (), Glycoprotéine hémagglutinine du virus influenza (métabolisme), Souris, Souris de lignée BALB C, Virus de la grippe A (), Virus de la grippe A (croissance et développement).
- MESH :
- biosynthèse : Antigènes d'histocompatibilité de classe II.
- croissance et développement : Virus de la grippe A.
- immunologie : Antigènes d'histocompatibilité de classe II, Cellules dendritiques.
- métabolisme : Glycoprotéine hémagglutinine du virus influenza.
- virologie : Cellules dendritiques.
- Animaux, Expression des gènes, Femelle, Glycoprotéine hémagglutinine du virus influenza, Souris, Souris de lignée BALB C, Virus de la grippe A.
English descriptors
- KwdEn :
- Animals, Dendritic Cells (immunology), Dendritic Cells (virology), Female, Gene Expression, Hemagglutinin Glycoproteins, Influenza Virus (classification), Hemagglutinin Glycoproteins, Influenza Virus (metabolism), Histocompatibility Antigens Class II (biosynthesis), Histocompatibility Antigens Class II (immunology), Influenza A virus (classification), Influenza A virus (growth & development), Mice, Mice, Inbred BALB C.
- MESH :
- chemical , biosynthesis : Histocompatibility Antigens Class II.
- chemical , classification : Hemagglutinin Glycoproteins, Influenza Virus.
- classification : Influenza A virus.
- growth & development : Influenza A virus.
- immunology : Dendritic Cells, Histocompatibility Antigens Class II.
- chemical , metabolism : Hemagglutinin Glycoproteins, Influenza Virus.
- virology : Dendritic Cells.
- Animals, Female, Gene Expression, Mice, Mice, Inbred BALB C.
Abstract
Dendritic cells (DC) play a key role in antiviral immunity, functioning both as innate effector cells in early phases of the immune response and subsequently as antigen-presenting cells that activate the adaptive immune response. In the murine respiratory tract, there are several respiratory dendritic cell (RDC) subsets, including CD103(+) DC, CD11b(hi) DC, monocyte/macrophage DC, and plasmacytoid DC. However, little is known about the interaction between these tissue-resident RDC and viruses that are encountered during natural infection in the respiratory tract. Here, we show both in vitro and in vivo that the susceptibility of murine RDC to infection with type A influenza virus varies with the level of MHC class II expression by RDC and with the virus strain. Both CD103(+) and CD11b(hi) RDC, which express the highest basal level of major histocompatibility complex (MHC) class II, are highly susceptible to infection by type A influenza virus. However, efficient infection is restricted to type A influenza virus strains of the H2N2 subtype. Furthermore, enhanced infectivity by viruses of the H2N2 subtype is linked to expression of the I-E MHC class II locus product. These results suggest a potential novel role for MHC class II molecules in influenza virus infection and pathogenesis in the respiratory tract.
DOI: 10.1128/JVI.05830-11
PubMed: 21917972
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000161
Links to Exploration step
pubmed:21917972Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.</title><author><name sortKey="Hargadon, Kristian M" sort="Hargadon, Kristian M" uniqKey="Hargadon K" first="Kristian M" last="Hargadon">Kristian M. Hargadon</name><affiliation wicri:level="1"><nlm:affiliation>Carter Immunology Center, UVA, P.O. Box 801386, Charlottesville, VA 22908, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Carter Immunology Center, UVA, P.O. Box 801386, Charlottesville, VA 22908</wicri:regionArea></affiliation></author><author><name sortKey="Zhou, Haixia" sort="Zhou, Haixia" uniqKey="Zhou H" first="Haixia" last="Zhou">Haixia Zhou</name></author><author><name sortKey="Albrecht, Randy A" sort="Albrecht, Randy A" uniqKey="Albrecht R" first="Randy A" last="Albrecht">Randy A. Albrecht</name></author><author><name sortKey="Dodd, Haley A" sort="Dodd, Haley A" uniqKey="Dodd H" first="Haley A" last="Dodd">Haley A. Dodd</name></author><author><name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name></author><author><name sortKey="Braciale, Thomas J" sort="Braciale, Thomas J" uniqKey="Braciale T" first="Thomas J" last="Braciale">Thomas J. Braciale</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21917972</idno><idno type="pmid">21917972</idno><idno type="doi">10.1128/JVI.05830-11</idno><idno type="wicri:Area/PubMed/Corpus">000161</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000161</idno><idno type="wicri:Area/PubMed/Curation">000161</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000161</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.</title><author><name sortKey="Hargadon, Kristian M" sort="Hargadon, Kristian M" uniqKey="Hargadon K" first="Kristian M" last="Hargadon">Kristian M. Hargadon</name><affiliation wicri:level="1"><nlm:affiliation>Carter Immunology Center, UVA, P.O. Box 801386, Charlottesville, VA 22908, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Carter Immunology Center, UVA, P.O. Box 801386, Charlottesville, VA 22908</wicri:regionArea></affiliation></author><author><name sortKey="Zhou, Haixia" sort="Zhou, Haixia" uniqKey="Zhou H" first="Haixia" last="Zhou">Haixia Zhou</name></author><author><name sortKey="Albrecht, Randy A" sort="Albrecht, Randy A" uniqKey="Albrecht R" first="Randy A" last="Albrecht">Randy A. Albrecht</name></author><author><name sortKey="Dodd, Haley A" sort="Dodd, Haley A" uniqKey="Dodd H" first="Haley A" last="Dodd">Haley A. Dodd</name></author><author><name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name></author><author><name sortKey="Braciale, Thomas J" sort="Braciale, Thomas J" uniqKey="Braciale T" first="Thomas J" last="Braciale">Thomas J. Braciale</name></author></analytic><series><title level="j">Journal of virology</title><idno type="eISSN">1098-5514</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Dendritic Cells (immunology)</term><term>Dendritic Cells (virology)</term><term>Female</term><term>Gene Expression</term><term>Hemagglutinin Glycoproteins, Influenza Virus (classification)</term><term>Hemagglutinin Glycoproteins, Influenza Virus (metabolism)</term><term>Histocompatibility Antigens Class II (biosynthesis)</term><term>Histocompatibility Antigens Class II (immunology)</term><term>Influenza A virus (classification)</term><term>Influenza A virus (growth & development)</term><term>Mice</term><term>Mice, Inbred BALB C</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antigènes d'histocompatibilité de classe II (biosynthèse)</term><term>Antigènes d'histocompatibilité de classe II (immunologie)</term><term>Cellules dendritiques (immunologie)</term><term>Cellules dendritiques (virologie)</term><term>Expression des gènes</term><term>Femelle</term><term>Glycoprotéine hémagglutinine du virus influenza ()</term><term>Glycoprotéine hémagglutinine du virus influenza (métabolisme)</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Virus de la grippe A ()</term><term>Virus de la grippe A (croissance et développement)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Histocompatibility Antigens Class II</term></keywords><keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en"><term>Hemagglutinin Glycoproteins, Influenza Virus</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe II</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe II</term><term>Cellules dendritiques</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Dendritic Cells</term><term>Histocompatibility Antigens Class II</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemagglutinin Glycoproteins, Influenza Virus</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycoprotéine hémagglutinine du virus influenza</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Cellules dendritiques</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Dendritic Cells</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Gene Expression</term><term>Mice</term><term>Mice, Inbred BALB C</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Expression des gènes</term><term>Femelle</term><term>Glycoprotéine hémagglutinine du virus influenza</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dendritic cells (DC) play a key role in antiviral immunity, functioning both as innate effector cells in early phases of the immune response and subsequently as antigen-presenting cells that activate the adaptive immune response. In the murine respiratory tract, there are several respiratory dendritic cell (RDC) subsets, including CD103(+) DC, CD11b(hi) DC, monocyte/macrophage DC, and plasmacytoid DC. However, little is known about the interaction between these tissue-resident RDC and viruses that are encountered during natural infection in the respiratory tract. Here, we show both in vitro and in vivo that the susceptibility of murine RDC to infection with type A influenza virus varies with the level of MHC class II expression by RDC and with the virus strain. Both CD103(+) and CD11b(hi) RDC, which express the highest basal level of major histocompatibility complex (MHC) class II, are highly susceptible to infection by type A influenza virus. However, efficient infection is restricted to type A influenza virus strains of the H2N2 subtype. Furthermore, enhanced infectivity by viruses of the H2N2 subtype is linked to expression of the I-E MHC class II locus product. These results suggest a potential novel role for MHC class II molecules in influenza virus infection and pathogenesis in the respiratory tract.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21917972</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>22</Issue><PubDate><Year>2011</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.</ArticleTitle><Pagination><MedlinePgn>11955-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.05830-11</ELocationID><Abstract><AbstractText>Dendritic cells (DC) play a key role in antiviral immunity, functioning both as innate effector cells in early phases of the immune response and subsequently as antigen-presenting cells that activate the adaptive immune response. In the murine respiratory tract, there are several respiratory dendritic cell (RDC) subsets, including CD103(+) DC, CD11b(hi) DC, monocyte/macrophage DC, and plasmacytoid DC. However, little is known about the interaction between these tissue-resident RDC and viruses that are encountered during natural infection in the respiratory tract. Here, we show both in vitro and in vivo that the susceptibility of murine RDC to infection with type A influenza virus varies with the level of MHC class II expression by RDC and with the virus strain. Both CD103(+) and CD11b(hi) RDC, which express the highest basal level of major histocompatibility complex (MHC) class II, are highly susceptible to infection by type A influenza virus. However, efficient infection is restricted to type A influenza virus strains of the H2N2 subtype. Furthermore, enhanced infectivity by viruses of the H2N2 subtype is linked to expression of the I-E MHC class II locus product. These results suggest a potential novel role for MHC class II molecules in influenza virus infection and pathogenesis in the respiratory tract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hargadon</LastName><ForeName>Kristian M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Carter Immunology Center, UVA, P.O. Box 801386, Charlottesville, VA 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Haixia</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Randy A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Dodd</LastName><ForeName>Haley A</ForeName><Initials>HA</Initials></Author><Author ValidYN="Y"><LastName>García-Sastre</LastName><ForeName>Adolfo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Braciale</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI037293</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI-37293</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL-33391</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007496</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>266200700010C</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U-19 AI-83024</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5 T32 AI007496-13</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5 T32 AI055432-06</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL033391</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI015608</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI-15608</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI083025</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI083024</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19AI083025</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI055432</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN266200700010C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000949">Histocompatibility Antigens Class II</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="Y">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019267" MajorTopicYN="N">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000949" MajorTopicYN="N">Histocompatibility Antigens Class II</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21917972</ArticleId><ArticleId IdType="pii">JVI.05830-11</ArticleId><ArticleId IdType="doi">10.1128/JVI.05830-11</ArticleId><ArticleId IdType="pmc">PMC3209325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annu Rev Med. 2000;51:407-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10774473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1987 Jan;61(1):214-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3491221</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1991 Aug;72 ( Pt 8):1905-11</Citation><ArticleIdList><ArticleId IdType="pubmed">1651984</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1992 Aug 1;176(2):519-29</Citation><ArticleIdList><ArticleId IdType="pubmed">1386874</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1997 Jun;71(6):4657-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9151859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1998 Mar 19;392(6673):245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9521319</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunobiology. 1998 Mar;198(5):552-67</Citation><ArticleIdList><ArticleId IdType="pubmed">9561373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ther. 1999 Jul;6(7):1258-66</Citation><ArticleIdList><ArticleId IdType="pubmed">10455434</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18153-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15601777</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 May 1;174(9):5332-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15843530</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Aug 1;175(3):1609-18</Citation><ArticleIdList><ArticleId IdType="pubmed">16034100</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Feb 15;176(4):2161-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16455972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2006 May 4;441(7089):101-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Mar 15;178(6):3368-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17339430</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2007 Apr-May;85(3):182-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17262055</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2007 Aug;27(2):240-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17723216</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Oct 1;179(7):4711-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17878370</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Med (Berl). 2007 Oct;85(10):1057-68</Citation><ArticleIdList><ArticleId IdType="pubmed">17891367</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2007 Oct;171(4):1215-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17717141</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Jan;82(1):335-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2008 Mar;22(3):733-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17925493</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 May;82(10):4908-19</Citation><ArticleIdList><ArticleId IdType="pubmed">18353940</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2008 Jul 7;205(7):1621-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18591406</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009;4(1):e4204</Citation><ArticleIdList><ArticleId IdType="pubmed">19145246</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2000;69:531-69</Citation><ArticleIdList><ArticleId IdType="pubmed">10966468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Dec;74(24):11825-31</Citation><ArticleIdList><ArticleId IdType="pubmed">11090182</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2001 Mar;3(3):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">11273782</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2003 Feb;18(2):265-77</Citation><ArticleIdList><ArticleId IdType="pubmed">12594953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2003 Dec;3(12):994-1003</Citation><ArticleIdList><ArticleId IdType="pubmed">14647481</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15070767</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2004 Jul 5;200(1):89-98</Citation><ArticleIdList><ArticleId IdType="pubmed">15238608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Jul 15;173(2):1209-18</Citation><ArticleIdList><ArticleId IdType="pubmed">15240712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1978 Jan 5;271(5640):66-7</Citation><ArticleIdList><ArticleId IdType="pubmed">305001</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1980 Aug;125(2):940-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7391587</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1985 Feb;134(2):757-60</Citation><ArticleIdList><ArticleId IdType="pubmed">3155540</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1985 Apr 10;260(7):4046-54</Citation><ArticleIdList><ArticleId IdType="pubmed">3980466</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1985 Nov;135(5):3524-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3876388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1985 Sep;3(3 Suppl):241-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3877381</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Nov;60(2):476-82</Citation><ArticleIdList><ArticleId IdType="pubmed">3490581</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Jun;74(12):5460-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10823850</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000161 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000161 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21917972
|texte= Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21917972" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |